RIBER SA (ALRIB.PA) Fundamental Analysis & Valuation

EPA:ALRIB • FR0000075954

Current stock price

5.52 EUR
-0.2 (-3.5%)
Last:

This ALRIB.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALRIB.PA Profitability Analysis

1.1 Basic Checks

  • ALRIB had positive earnings in the past year.
  • ALRIB had a positive operating cash flow in the past year.
  • Each year in the past 5 years ALRIB has been profitable.
  • ALRIB had a positive operating cash flow in 4 of the past 5 years.
ALRIB.PA Yearly Net Income VS EBIT VS OCF VS FCFALRIB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

  • ALRIB's Return On Assets of 6.75% is in line compared to the rest of the industry. ALRIB outperforms 44.83% of its industry peers.
  • ALRIB has a Return On Equity (14.77%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 12.44%, ALRIB is in line with its industry, outperforming 58.62% of the companies in the same industry.
Industry RankSector Rank
ROA 6.75%
ROE 14.77%
ROIC 12.44%
ROA(3y)5.22%
ROA(5y)3.97%
ROE(3y)11.47%
ROE(5y)8.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALRIB.PA Yearly ROA, ROE, ROICALRIB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • ALRIB has a Profit Margin of 8.26%. This is in the lower half of the industry: ALRIB underperforms 63.79% of its industry peers.
  • ALRIB's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ALRIB (9.86%) is worse than 70.69% of its industry peers.
  • In the last couple of years the Operating Margin of ALRIB has grown nicely.
  • The Gross Margin of ALRIB (36.56%) is worse than 77.59% of its industry peers.
  • ALRIB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.86%
PM (TTM) 8.26%
GM 36.56%
OM growth 3Y33.22%
OM growth 5Y31.15%
PM growth 3Y28.64%
PM growth 5Y25.02%
GM growth 3Y0.64%
GM growth 5Y4.07%
ALRIB.PA Yearly Profit, Operating, Gross MarginsALRIB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALRIB.PA Health Analysis

2.1 Basic Checks

  • ALRIB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • ALRIB has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALRIB remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, ALRIB has an improved debt to assets ratio.
ALRIB.PA Yearly Shares OutstandingALRIB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ALRIB.PA Yearly Total Debt VS Total AssetsALRIB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • ALRIB has an Altman-Z score of 4.27. This indicates that ALRIB is financially healthy and has little risk of bankruptcy at the moment.
  • ALRIB's Altman-Z score of 4.27 is on the low side compared to the rest of the industry. ALRIB is outperformed by 60.34% of its industry peers.
  • ALRIB has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.02, ALRIB belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 4.27
ROIC/WACC1.08
WACC11.49%
ALRIB.PA Yearly LT Debt VS Equity VS FCFALRIB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • ALRIB has a Current Ratio of 1.43. This is a normal value and indicates that ALRIB is financially healthy and should not expect problems in meeting its short term obligations.
  • ALRIB's Current ratio of 1.43 is on the low side compared to the rest of the industry. ALRIB is outperformed by 87.93% of its industry peers.
  • ALRIB has a Quick Ratio of 1.43. This is a bad value and indicates that ALRIB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALRIB has a worse Quick ratio (0.51) than 96.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.51
ALRIB.PA Yearly Current Assets VS Current LiabilitesALRIB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALRIB.PA Growth Analysis

3.1 Past

  • ALRIB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.91%.
  • ALRIB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.74% yearly.
  • The Revenue has decreased by -6.64% in the past year.
  • ALRIB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.20% yearly.
EPS 1Y (TTM)-30.91%
EPS 3Y41.89%
EPS 5Y30.74%
EPS Q2Q%-594.94%
Revenue 1Y (TTM)-6.64%
Revenue growth 3Y9.68%
Revenue growth 5Y4.2%
Sales Q2Q%-22.1%

3.2 Future

  • ALRIB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.42% yearly.
  • The Revenue is expected to grow by 9.09% on average over the next years. This is quite good.
EPS Next Y0%
EPS Next 2Y15.47%
EPS Next 3Y17.42%
EPS Next 5YN/A
Revenue Next Year-3.12%
Revenue Next 2Y6.74%
Revenue Next 3Y9.09%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALRIB.PA Yearly Revenue VS EstimatesALRIB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALRIB.PA Yearly EPS VS EstimatesALRIB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALRIB.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 36.80, ALRIB can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as ALRIB.
  • The average S&P500 Price/Earnings ratio is at 24.88. ALRIB is valued slightly more expensive when compared to this.
  • With a Price/Forward Earnings ratio of 19.14, ALRIB is valued on the expensive side.
  • 79.31% of the companies in the same industry are more expensive than ALRIB, based on the Price/Forward Earnings ratio.
  • ALRIB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 36.8
Fwd PE 19.14
ALRIB.PA Price Earnings VS Forward Price EarningsALRIB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALRIB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.81
ALRIB.PA Per share dataALRIB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALRIB's earnings are expected to grow with 17.42% in the coming years.
PEG (NY)N/A
PEG (5Y)1.2
EPS Next 2Y15.47%
EPS Next 3Y17.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ALRIB.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.40%, ALRIB has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.78, ALRIB pays a better dividend. On top of this ALRIB pays more dividend than 86.21% of the companies listed in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.89, ALRIB is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.4%

5.2 History

  • The dividend of ALRIB is nicely growing with an annual growth rate of 6.99%!
Dividend Growth(5Y)6.99%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • ALRIB pays out 53.27% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of ALRIB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP53.27%
EPS Next 2Y15.47%
EPS Next 3Y17.42%
ALRIB.PA Yearly Income VS Free CF VS DividendALRIB.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M
ALRIB.PA Dividend Payout.ALRIB.PA Dividend Payout, showing the Payout Ratio.ALRIB.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ALRIB.PA Fundamentals: All Metrics, Ratios and Statistics

RIBER SA

EPA:ALRIB (3/27/2026, 7:00:00 PM)

5.52

-0.2 (-3.5%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A
Earnings (Next)04-08
Inst Owners0.53%
Inst Owner ChangeN/A
Ins Owners23.55%
Ins Owner ChangeN/A
Market Cap117.30M
Revenue(TTM)38.12M
Net Income(TTM)3.15M
Analysts84.44
Price Target5.41 (-1.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.4%
Yearly Dividend0.07
Dividend Growth(5Y)6.99%
DP53.27%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)35.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.95%
Valuation
Industry RankSector Rank
PE 36.8
Fwd PE 19.14
P/S 3.08
P/FCF N/A
P/OCF 56.23
P/B 5.5
P/tB 7.16
EV/EBITDA 20.81
EPS(TTM)0.15
EY2.72%
EPS(NY)0.29
Fwd EY5.22%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.1
OCFY1.78%
SpS1.79
BVpS1
TBVpS0.77
PEG (NY)N/A
PEG (5Y)1.2
Graham Number1.84
Profitability
Industry RankSector Rank
ROA 6.75%
ROE 14.77%
ROCE 16.92%
ROIC 12.44%
ROICexc 12.44%
ROICexgc 15.99%
OM 9.86%
PM (TTM) 8.26%
GM 36.56%
FCFM N/A
ROA(3y)5.22%
ROA(5y)3.97%
ROE(3y)11.47%
ROE(5y)8.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y43.33%
ROICexgc growth 5Y7.91%
ROICexc growth 3Y40.09%
ROICexc growth 5Y10.78%
OM growth 3Y33.22%
OM growth 5Y31.15%
PM growth 3Y28.64%
PM growth 5Y25.02%
GM growth 3Y0.64%
GM growth 5Y4.07%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA 0.08
Cap/Depr 134.21%
Cap/Sales 7.07%
Interest Coverage 235
Cash Conversion 36.17%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.51
Altman-Z 4.27
F-Score4
WACC11.49%
ROIC/WACC1.08
Cap/Depr(3y)112.18%
Cap/Depr(5y)116.77%
Cap/Sales(3y)6.89%
Cap/Sales(5y)7.11%
Profit Quality(3y)540.29%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.91%
EPS 3Y41.89%
EPS 5Y30.74%
EPS Q2Q%-594.94%
EPS Next Y0%
EPS Next 2Y15.47%
EPS Next 3Y17.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.64%
Revenue growth 3Y9.68%
Revenue growth 5Y4.2%
Sales Q2Q%-22.1%
Revenue Next Year-3.12%
Revenue Next 2Y6.74%
Revenue Next 3Y9.09%
Revenue Next 5YN/A
EBIT growth 1Y-25.41%
EBIT growth 3Y46.12%
EBIT growth 5Y36.66%
EBIT Next Year41.67%
EBIT Next 3Y15%
EBIT Next 5YN/A
FCF growth 1Y-119.71%
FCF growth 3YN/A
FCF growth 5Y-14.36%
OCF growth 1Y-56.2%
OCF growth 3Y42.71%
OCF growth 5Y-5.01%

RIBER SA / ALRIB.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for RIBER SA?

ChartMill assigns a fundamental rating of 4 / 10 to ALRIB.PA.


Can you provide the valuation status for RIBER SA?

ChartMill assigns a valuation rating of 2 / 10 to RIBER SA (ALRIB.PA). This can be considered as Overvalued.


What is the profitability of ALRIB stock?

RIBER SA (ALRIB.PA) has a profitability rating of 4 / 10.


What is the valuation of RIBER SA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for RIBER SA (ALRIB.PA) is 36.8 and the Price/Book (PB) ratio is 5.5.


What is the earnings growth outlook for RIBER SA?

The Earnings per Share (EPS) of RIBER SA (ALRIB.PA) is expected to decline by 0% in the next year.